Still room for innovators in women's health, says Bayer
This article was originally published in Scrip
Executive Summary
Women's health – a hot area at the moment for many generic companies – is one of Bayer Healthcare's key therapy areas of focus; and there is plenty of room for more innovation-based R&D in this space, according to UK & Ireland chief Dr Alexander Moscho.
You may also be interested in...
Keeping Track: Ilaris Adds Three Rare Disease Claims; Sirukumab Submitted; Exondys 51's Surprising Approval
The latest drug development news and highlights from our FDA Performance Tracker.
Accessing Venture Debt From The EIB
Tips from Gergely Krajcsi, senior investment officer at the European Investment Bank, on how biotechs can access loans for faster growth.
In Vivo's 2024 Rising Leaders At A Glance
Top 30 leaders: see the list of industry influencers highlighted in the fifth edition of In Vivo's Rising Leaders series.